Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features

Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CMR, et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1999;96(25):14412–7. de Greef JC, Wang J, Balog J, den Dunnen J, Frants RR, Straasheijm KR, et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet. 2011;88(6):796–804. Thijssen PE, Ito Y, Grillo G, Wang J, Velasco G, Nitta H, et al. Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome. Nat Commun. 2015;6:7870. Weemaes CM, van Tol MJD, Wang J, van Ostaijen-ten Dam MM, van Eggermond MCJA, Thijssen PE, et al. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet. 2013;21(11):1219–25. Hagleitner MM, Lankester A, Maraschio P, Hultén M, Fryns JP, Schuetz C, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008;45(2):93–9. Gennery AR, Slatter MA, Bredius RG, Hagleitner MM, Weemaes C, Cant AJ, et al. Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome. Pediatrics. 2007;120(5):e1341–4. Kaya N, al-Muhsen S, al-Saud B, al-Bakheet A, Colak D, al-Ghonaium A, et al. ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis. J Clin Immunol. 2011;31(2):245–52. Arsham MS, Barch MJ, Lawce HJ, editors. The AGT cytogenetics laboratory manual, 4th ed. Hoboken:Wiley-Blackwell; 2017. p. 201. Boogaard ML, et al. Expanding the mutation spectrum in ICF syndrome: evidence for a gender bias in ICF2. Clin Genet. 2017:1–8.